AAAAAA

   
Results: 1-14 |
Results: 14
THERAPY OF A XENOGRAFTED HUMAN COLONIC-CARCINOMA USING CISPLATIN OR DOXORUBICIN ENCAPSULATED IN LONG-CIRCULATING PEGYLATED STEALTH LIPOSOMES
Authors: VAAGE J DONOVAN D WIPFF E ABRA R COLBERN G USTER P WORKING P
Citation: J. Vaage et al., THERAPY OF A XENOGRAFTED HUMAN COLONIC-CARCINOMA USING CISPLATIN OR DOXORUBICIN ENCAPSULATED IN LONG-CIRCULATING PEGYLATED STEALTH LIPOSOMES, International journal of cancer, 80(1), 1999, pp. 134-137
INHIBITION OF MOUSE MAMMARY-CARCINOMA DEVELOPMENT WITH DOXORUBICIN INLIPOSOMES
Authors: VAAGE J WORKING P USTER P
Citation: J. Vaage et al., INHIBITION OF MOUSE MAMMARY-CARCINOMA DEVELOPMENT WITH DOXORUBICIN INLIPOSOMES, International journal of cancer, 75(1), 1998, pp. 158-159
EFFECT OF TUMOR SIZE ON UPTAKE OF 111IN-DTPA-LABELED STEALTH LIPOSOMES (IDLSL) IN A TUMOR XENOGRAFT MODEL
Authors: HARRINGTON K ROWLINSONBUSZA G ABRA R USTER P STEWART S
Citation: K. Harrington et al., EFFECT OF TUMOR SIZE ON UPTAKE OF 111IN-DTPA-LABELED STEALTH LIPOSOMES (IDLSL) IN A TUMOR XENOGRAFT MODEL, British Journal of Cancer, 78, 1998, pp. 25-25
STEALTH LIPOSOME-ENTRAPPED DOXORUBICIN (SLED) AND CISPLATIN (SLEC) VERSUS HEAD AND NECK XENOGRAFT TUMORS
Authors: HARRINGTON K ROWLINSONBUSZA G USTER P STEWART S
Citation: K. Harrington et al., STEALTH LIPOSOME-ENTRAPPED DOXORUBICIN (SLED) AND CISPLATIN (SLEC) VERSUS HEAD AND NECK XENOGRAFT TUMORS, British Journal of Cancer, 78, 1998, pp. 26-26
STEALTH LIPOSOME-ENCAPSULATED DOXORUBICIN (SLED) AND CISPLATIN (SLEC)FOR TARGETED RADIOSENSITIZATION IN XENOGRAFT TUMORS
Authors: HARRINGTON K ROWLINSONBUSZA G USTER P STEWART S
Citation: K. Harrington et al., STEALTH LIPOSOME-ENCAPSULATED DOXORUBICIN (SLED) AND CISPLATIN (SLEC)FOR TARGETED RADIOSENSITIZATION IN XENOGRAFT TUMORS, British Journal of Cancer, 78, 1998, pp. 27-27
STEALTH LIPOSOME-ENCAPSULATED IODODEOXYURIDINE (SLIUDR) FOR TARGETED RADIOSENSITIZATION IN XENOGRAFT TUMORS
Authors: HARRINGTON K ROWLINSONBUSZA G USTER P STEWART S
Citation: K. Harrington et al., STEALTH LIPOSOME-ENCAPSULATED IODODEOXYURIDINE (SLIUDR) FOR TARGETED RADIOSENSITIZATION IN XENOGRAFT TUMORS, British Journal of Cancer, 78, 1998, pp. 28-28
BIODISTRIBUTION AND PHARMACOKINETICS OF 111IN-DTPA-LABELED STEALTH LIPOSOMES (IDLSL) AFTER INTRAPERITONEAL INJECTION IN MICE
Authors: HARRINGTON K USTER P STEWART S
Citation: K. Harrington et al., BIODISTRIBUTION AND PHARMACOKINETICS OF 111IN-DTPA-LABELED STEALTH LIPOSOMES (IDLSL) AFTER INTRAPERITONEAL INJECTION IN MICE, British Journal of Cancer, 78, 1998, pp. 29-29
BIODISTRIBUTION AND PHARMACOKINETICS 111IN-DTPA-LABELED STEALTH LIPOSOMES (IDLSL) IN PATIENTS WITH SOLID CANCERS
Authors: HARRINGTON K ABRA R USTER P STEWART S
Citation: K. Harrington et al., BIODISTRIBUTION AND PHARMACOKINETICS 111IN-DTPA-LABELED STEALTH LIPOSOMES (IDLSL) IN PATIENTS WITH SOLID CANCERS, British Journal of Cancer, 78, 1998, pp. 29-29
BIODISTRIBUTION AND PHARMACOKINETICS OF 111IN-DTPA-LABELED STEALTH LIPOSOMES (IDLSL) IN A HUMAN TUMOR XENOGRAFT MODEL
Authors: HARRINGTON K ROWLINSONBUSZA G USTER P ABRA R STEWART S
Citation: K. Harrington et al., BIODISTRIBUTION AND PHARMACOKINETICS OF 111IN-DTPA-LABELED STEALTH LIPOSOMES (IDLSL) IN A HUMAN TUMOR XENOGRAFT MODEL, British Journal of Cancer, 78, 1998, pp. 44-44
STEALTH LIPOSOME-ENTRAPPED DOXORUBICIN (SLED) AND CISPLATIN (SLEC) VERSUS HEAD AND NECK XENOGRAFT TUMORS
Authors: HARRINGTON KJ ROWLINSONBUSZA G USTER P STEWART JSW
Citation: Kj. Harrington et al., STEALTH LIPOSOME-ENTRAPPED DOXORUBICIN (SLED) AND CISPLATIN (SLEC) VERSUS HEAD AND NECK XENOGRAFT TUMORS, European journal of cancer, 33, 1997, pp. 802-802
TUMOR UPTAKE OF DOXORUBICIN IN POLYETHYLENE GLYCOL-COATED LIPOSOMES AND THERAPEUTIC EFFECT AGAINST A XENOGRAFTED HUMAN PANCREATIC-CARCINOMA
Authors: VAAGE J DONOVAN D USTER P WORKING P
Citation: J. Vaage et al., TUMOR UPTAKE OF DOXORUBICIN IN POLYETHYLENE GLYCOL-COATED LIPOSOMES AND THERAPEUTIC EFFECT AGAINST A XENOGRAFTED HUMAN PANCREATIC-CARCINOMA, British Journal of Cancer, 75(4), 1997, pp. 482-486
THE EFFECT OF VINCRISTINE-POLYANION COMPLEXES IN STEALTH LIPOSOMES ONPHARMACOKINETICS, TOXICITY AND ANTI TUMOR-ACTIVITY
Authors: ZHU G OTO E VAAGE J QUINN Y NEWMAN M ENGBERS C USTER P
Citation: G. Zhu et al., THE EFFECT OF VINCRISTINE-POLYANION COMPLEXES IN STEALTH LIPOSOMES ONPHARMACOKINETICS, TOXICITY AND ANTI TUMOR-ACTIVITY, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 138-142
PROPHYLAXIS AND THERAPY OF MOUSE MAMMARY CARCINOMAS WITH DOXORUBICIN AND VINCRISTINE ENCAPSULATED IN STERICALLY STABILIZED LIPOSOMES
Authors: VAAGE J DONOVAN D LOFTUS T USTER P WORKING P
Citation: J. Vaage et al., PROPHYLAXIS AND THERAPY OF MOUSE MAMMARY CARCINOMAS WITH DOXORUBICIN AND VINCRISTINE ENCAPSULATED IN STERICALLY STABILIZED LIPOSOMES, European journal of cancer, 31A(3), 1995, pp. 367-372
THERAPY OF MOUSE MAMMARY CARCINOMAS WITH VINCRISTINE AND DOXORUBICIN ENCAPSULATED IN STERICALLY STABILIZED LIPOSOMES
Authors: VAAGE J DONOVAN D MAYHEW E USTER P WOODLE M
Citation: J. Vaage et al., THERAPY OF MOUSE MAMMARY CARCINOMAS WITH VINCRISTINE AND DOXORUBICIN ENCAPSULATED IN STERICALLY STABILIZED LIPOSOMES, International journal of cancer, 54(6), 1993, pp. 959-964
Risultati: 1-14 |